Cargando…
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Amyotrophic lateral sclerosis is a relentless neurodegenerative disease that is mostly fatal within 3–5 years and is diagnosed on evidence of progressive upper and lower motor neuron degeneration. Around 15% of those with amyotrophic lateral sclerosis also have frontotemporal degeneration, and gene...
Autores principales: | Rogers, Mary-Louise, Schultz, David W, Karnaros, Vassilios, Shepheard, Stephanie R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631861/ https://www.ncbi.nlm.nih.gov/pubmed/37946793 http://dx.doi.org/10.1093/braincomms/fcad287 |
Ejemplares similares
-
The Extracellular Domain of Neurotrophin Receptor p75 as a Candidate Biomarker for Amyotrophic Lateral Sclerosis
por: Shepheard, Stephanie R., et al.
Publicado: (2014) -
Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohort
por: Jia, Rui, et al.
Publicado: (2017) -
Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
por: Ranganathan, Ramya, et al.
Publicado: (2020) -
Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis
por: Wilson, Meghan E., et al.
Publicado: (2010) -
New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis
por: Chen, Xueping, et al.
Publicado: (2015)